Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs3840047 | chr16:89800163 | C/CG | 0.000194 | 174 | 25.87 | 20.28 | 36.37 | KM Plot |
PCPG | rs3853618 | chr12:31285991 | A/C | 3.6E-5 | 170 | 24.77 | 28.38 | 12.22 | KM Plot |
PCPG | rs3892297 | chr7:105152173 | G/A | 2.77E-6 | 176 | 20.13 | 29.43 | 2.28 | KM Plot |
PCPG | rs3892298 | chr7:105152187 | A/G | 5.56E-5 | 177 | 20.17 | 29.43 | 2.28 | KM Plot |
PCPG | rs3912029 | chr13:114167715 | G/T | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs3922633 | chr16:89577046 | C/T | 0.000308 | 178 | 26.78 | 25.53 | 19.53 | KM Plot |
PCPG | rs3922634 | chr16:89576766 | T/C | 0.000331 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs393329 | chr16:12070422 | T/C | 0.000306 | 172 | 24.35 | 25.2 | 25.77 | KM Plot |
PCPG | rs3935312 | chr16:89592077 | G/A | 0.000213 | 175 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs394616 | chr5:179418134 | T/G | 0.000243 | 176 | 24.1 | 34.73 | 14.83 | KM Plot |
PCPG | rs4026181 | chr3:53508040 | A/G | 0.000243 | 172 | 31.43 | 24.5 | 25.53 | KM Plot |
PCPG | rs4072903 | chr2:242537132 | G/A | 2.99E-5 | 176 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs4072904 | chr2:242537706 | G/A | 2.99E-5 | 176 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs4072905 | chr2:242537692 | C/T | 4.87E-11 | 177 | 25.87 | 24.7 | 10.3 | KM Plot |
PCPG | rs4074939 | chr7:105152528 | G/A | 5.56E-5 | 177 | 20.17 | 29.43 | 2.28 | KM Plot |